![Ryan Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 206 978 $ in data 30/06/2026
Ryan H.
Wong is Chief Financial Officer & Executive VP at Sarepta Therapeutics, Inc. since 2025.
Education includes undergraduate studies at the University of California, Irvine and graduate studies at USC Marshall School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2026 | 11.518 ( 0,01% ) | 206 978 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 16/07/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
 USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
